FEBUXOSTAT
Surixtat

SURIXTAT is indicated for the treatment of chronic hyperuricemia in patients with urate deposition, including those with a history or presence of tophus and/or gouty arthritis.

Packaging: box of 30’s
Shelf Life: 36 months
Origin: India
Dosage Form: Film-Coated Tablet